Daniella Beckman
CIK 1513422 · Chief Financial Officer · last filed 2026-06-11
Daniella Beckman is a Chief Financial Officer who has filed 32 SEC Form 4 insider transactions across 7 companies since 2011. The most recent filing, for UPB, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$198.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.71M
7
32
-$198.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UPB | Director | — | $6.10 | — | $0 | 3 | 2026-06-11 |
| TNGX | Chief Financial Officer | 184,410 | $30.94 | $5.71M | -$198.7K | 8 | 2026-02-04 |
| Blueprint Medicines Corp (BPMC) Delisted | Director | 10,842 | $129.46 | $1.40M | $0 | 6 | 2025-07-21 |
| VOR | Director | — | $14.36 | — | $0 | 5 | 2025-05-23 |
| TBIO | Director | — | $0.00 | — | $0 | 4 | 2021-09-14 |
| 5:01 Acquisition Corp. (FVAM) Delisted | Director | — | $10.00 | — | $0 | 1 | 2020-10-20 |
| IDENIX PHARMACEUTICALS INC (IDIX) Delisted | SVP, CFO and Treasurer | — | — | — | $0 | 5 | 2014-08-05 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | UPB | Grant (A) | — | $0 | EDGAR |
| 2026-02-04 | TNGX | Mixed | +34,013 | -$126.5K | EDGAR |
| 2025-07-21 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | −14,744 | $0 | EDGAR |
| 2025-06-24 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +3,902 | $499.9K | EDGAR |
| 2025-06-12 | UPB | Grant (A) | — | $0 | EDGAR |
| 2025-05-23 | VOR | Grant (A) | — | $0 | EDGAR |
| 2025-02-06 | TNGX | Sell (S) | −8,232 | -$25.3K | EDGAR |
| 2025-02-05 | TNGX | Grant (A) | +26,119 | $0 | EDGAR |
| 2024-10-15 | UPB | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +2,242 | $0 | EDGAR |